TY  - JOUR
AU  - Lo, Louisa L
AU  - Collins, Ian M
AU  - Bressel, Mathias
AU  - Butow, Phyllis
AU  - Emery, Jon
AU  - Keogh, Louise
AU  - Weideman, Prue
AU  - Steel, Emma
AU  - Hopper, John L
AU  - Trainer, Alison H
AU  - Mann, Gregory B
AU  - Bickerstaffe, Adrian
AU  - Antoniou, Antonis C
AU  - Cuzick, Jack
AU  - Phillips, Kelly-Anne
PY  - 2018
DA  - 2018/11/07
TI  - The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing
JO  - JMIR Formativ Res
SP  - e24
VL  - 2
IS  - 2
KW  - clinical decision support
KW  - breast cancer
KW  - BRCA1 gene
KW  - BRCA2 gene
KW  - risk
KW  - preventive health
KW  - screening
AB  - Background: iPrevent estimates breast cancer (BC) risk and provides tailored risk management information. Objective: The objective of this study was to assess the usability and acceptability of the iPrevent prototype. Methods: Clinicians were eligible for participation in the study if they worked in primary care, breast surgery, or genetics clinics. Female patients aged 18-70 years with no personal cancer history were eligible. Clinicians were first familiarized with iPrevent using hypothetical paper-based cases and then actor scenarios; subsequently, they used iPrevent with their patients. Clinicians and patients completed the System Usability Scale (SUS) and an Acceptability questionnaire 2 weeks after using iPrevent; patients also completed measures of BC worry, anxiety, risk perception, and knowledge pre- and 2 weeks post-iPrevent. Data were summarized using descriptive statistics. Results: The SUS and Acceptability questionnaires were completed by 19 of 20 clinicians and 37 of 43 patients. Usability was above average (SUS score >68) for 68% (13/19) clinicians and 76% (28/37) patients. The amount of information provided by iPrevent was reported as “about right” by 89% (17/19) clinicians and 89% (33/37) patients and 95% (18/19) and 97% (36/37), respectively, would recommend iPrevent to others, although 53% (10/19) clinicians and 27% (10/37) patients found it too long. Exploratory analyses suggested that iPrevent could improve risk perception, decrease frequency of BC worry, and enhance BC prevention knowledge without changing state anxiety. Conclusions: The iPrevent prototype demonstrated good usability and acceptability. Because concerns about length could be an implementation barrier, data entry has been abbreviated in the publicly available version of iPrevent. 
SN  - 2561-326X
UR  - http://formative.jmir.org/2018/2/e24/
UR  - https://doi.org/10.2196/formative.9935
UR  - http://www.ncbi.nlm.nih.gov/pubmed/30684421
DO  - 10.2196/formative.9935
ID  - info:doi/10.2196/formative.9935
ER  -